MARKET WIRE NEWS
  1. Home
  2. Stock
  3. MLTX
  4. News
MLTX
Quote
Short
News
Articles
Message Board

MoonLake Immunotherapeutics (NASDAQ : MLTX ) News

MoonLake Immunotherapeutics (NASDAQ: MLTX) News Releases

MLTX News Releases
MLTX : NASDAQ
Motley Fool
MoonLake Immunotherapeutics CFO Trims His Stake. Should Investors Be Concerned?
MLTX : NASDAQ
KlickAnalytics
Buy Recommendation Issued On MLTX By H.C. Wainwright
MLTX : NASDAQ
SeekingAlpha
MoonLake Immunotherapeutics GAAP EPS of -$0.98 misses by $0.07
MLTX : NASDAQ
GlobeNewswire
MoonLake Immunotherapeutics Announces Positive Outcome from its Final Pre-BLA Meeting with the U.S. FDA and Reports First Quarter 2026 Financial Results
MLTX : NASDAQ
Motley Fool
The CEO of MoonLake Immunotherapeutics Dumped Shares Worth $2.8 Million. Should Investors Avoid the Stock?
MLTX : NASDAQ
Motley Fool
Biotech Fund BVF Trims MoonLake Stake, Sells $63M in Shares
MLTX : NASDAQ
GlobeNewswire
MoonLake announces Week 40 Results from its Phase 3 Clinical Trials of Sonelokimab in Hidradenitis Suppurativa at the 2026 AAD Annual Meeting
MLTX : NASDAQ
SeekingAlpha
MoonLake upgraded at Rothschild & Co Redburn citing potential FDA nod for lead drug
MLTX : NASDAQ
Motley Fool
This Fund Bought $28 Million of a Beaten-Down Immunotherapy Stock Last Quarter. What Should Long-Term Investors Know?
MLTX : NASDAQ
US Earnings Reports
Expected US Company Earnings on Wednesday, February 25th, 2026
Next 10

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.